Clinical Trial Update: A Randomized Controlled Trial to Compare the Clinical Outcomes With Six Months of Therapy With Oral Itraconazole Versus Oral Voriconazole for Management of Treatment naïve Subjects With Chronic Pulmonary Aspergillosis [Phase 3]

View source ↗

Summary

Phase 3 randomized trial comparing six months of oral itraconazole versus oral voriconazole for treatment-naïve chronic pulmonary aspergillosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Aspergillosis

Drugs mentioned

• Itraconazole (Itraconazole)
• VORICONAZOLE (Voriconazole)

Snippet

Sponsor: Post Graduate Institute of Medical Education and Research, Chandigarh | Conditions: Chronic Pulmonary Aspergillosis | Phase 3 | Status: COMPLETED